TY - JOUR
T1 - The influence of airway obstruction and respiratory muscle strength on maximal voluntary ventilation in lung disease
AU - Aldrich, T. K.
AU - Arora, N. S.
AU - Rochester, D. F.
PY - 1982/1/1
Y1 - 1982/1/1
N2 - To assess the effects of airway conductance (Gaw) and respiratory muscle strength (RMS) on maximal voluntary ventilation (MVV), we studied 8 normal subjects (N), 8 patients with interstitial lung disease (ILD), and 16 with chronic airflow limitation (CAL). In the patients with ILD, RMS explains 83% of the variance in MVV (p < 0.005), but Gaw explains none. In the patients with CAL, Gaw and RMS explain, respectively, 65 and 34% of the variance in MVV (p < 0.02). Considering Gaw and RMS together increases the explained variance to 77% (p < 0.005). In groups CAL and N combined, Gaw and RMS explain 86% of the variance in MVV, with 71% explained by Gaw and 34% by RMS, which the other variable alone failed to explain (p < 0.005). When the data are normalized for age, sex, height, and lung volume, the influence of %RMS on %MVV is halved, but remains significant (p < 0.05). We conclude that RMS is a primary determinant of MVV in patients with ILD, and an important determinant in patients with CAL.
AB - To assess the effects of airway conductance (Gaw) and respiratory muscle strength (RMS) on maximal voluntary ventilation (MVV), we studied 8 normal subjects (N), 8 patients with interstitial lung disease (ILD), and 16 with chronic airflow limitation (CAL). In the patients with ILD, RMS explains 83% of the variance in MVV (p < 0.005), but Gaw explains none. In the patients with CAL, Gaw and RMS explain, respectively, 65 and 34% of the variance in MVV (p < 0.02). Considering Gaw and RMS together increases the explained variance to 77% (p < 0.005). In groups CAL and N combined, Gaw and RMS explain 86% of the variance in MVV, with 71% explained by Gaw and 34% by RMS, which the other variable alone failed to explain (p < 0.005). When the data are normalized for age, sex, height, and lung volume, the influence of %RMS on %MVV is halved, but remains significant (p < 0.05). We conclude that RMS is a primary determinant of MVV in patients with ILD, and an important determinant in patients with CAL.
UR - http://www.scopus.com/inward/record.url?scp=0019959277&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0019959277&partnerID=8YFLogxK
M3 - Article
C2 - 7103242
AN - SCOPUS:0019959277
SN - 1073-449X
VL - 126
SP - 195
EP - 199
JO - American Journal of Respiratory and Critical Care Medicine
JF - American Journal of Respiratory and Critical Care Medicine
IS - 2
ER -